Fasenra and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Fasenra (benralizumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Atrovent, and have Asthma.

The phase IV clinical study analyzes which people have Panic attacks when taking Fasenra. It is created by eHealthMe based on reports of 11,790 people who have side effects when taking Fasenra from the FDA, and is updated regularly.

What is Fasenra?

Fasenra has active ingredients of benralizumab. eHealthMe is studying from 11,805 Fasenra users. Check the latest studies of Fasenra.

What is Panic attacks?

Panic attacks is found to be associated with 2,390 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Jun, 15, 2026

11,790 people reported to have side effects when taking Fasenra.
Among them, 16 people (0.14%) have Panic attacks.

Among these 16 people:

How long have people been on Fasenra when they have Panic attacks? *

What is the gender of people who have Panic attacks when taking Fasenra? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Panic attacks when taking Fasenra? *

What are other drugs people take besides Fasenra? *

What are other side effects people have besides Panic attacks? *

Dyspnea (difficult or laboured breathing): 5 people, 31.25%
Fatigue (feeling of tiredness): 5 people, 31.25%
Stress And Anxiety: 5 people, 31.25%
Back Pain: 4 people, 25.00%
Depression: 4 people, 25.00%
Headache (pain in head): 4 people, 25.00%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 18.75%
Pneumonia: 3 people, 18.75%
Drug Ineffective: 3 people, 18.75%
Gait Disturbance: 3 people, 18.75%

What are the existing conditions these people have? *

Asthma: 11 people, 68.75%
Thyroid Diseases: 2 people, 12.50%
High Blood Cholesterol: 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 2 people, 12.50%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
Migraine (headache): 1 person, 6.25%
Infection: 1 person, 6.25%
Ill-Defined Disorder: 1 person, 6.25%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 6.25%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Fasenra and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fasenra:

Fasenra (11,805 reports)

Panic attacks treatments and more:

Panic attacks (65,704 reports)

Browse all side effects of Fasenra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,390 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benralizumab (the active ingredients of Fasenra) and Fasenra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.